Podcast: Cannabis investments – What you need to know
Cannabis investments – What you need to know (with Stuart Forbes, Co-founder at Rize ETF)
We’re excited to be on the Informed Choice Radio Podcast episode #498 with Martin Bamford where we give a general introduction to medical cannabis investments. What are the medical uses of cannabis? Is it going global? What are the growth opportunities within this industry? Stuart Forbes gives you a 30 minute introduction to all you need to know when it comes to investing in medical cannabis.
Stuart is a co-founder and our product lead. He is highly experienced in the full life-cycle development and management of ETF platforms. Stuart is a qualified solicitor and was previously Head of ETF Product Development at Legal & General Investment Management, and prior to that, at ETF Securities, where he was responsible for ETF development / structuring, platform management and legal.
Recorded on June 8th, 2020.
FLWR: The Rize Medical Cannabis and Life Sciences UCITS ETF seeks to track the Foxberry Medical Cannabis & Life Sciences Index. The objective of the Index is to provide exposure to companies involved in the global medical cannabis and cannabis-related life sciences sectors, with a focus on companies in the biotechnology/pharma and hemp and cannabidiol (CBD) sectors. The Index excludes companies that are considered to be either non-compliant with state and federal laws in the countries in which they operate and/or directly involved in the production and/or distribution of cannabis and/or cannabis-derived products containing more than hemp-defined levels of tetrahydrocannabinol (THC) for the recreational consumer market.
Capital at Risk Warning: An investment in the Fund(s) involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. The Funds may be registered or otherwise approved for distribution to the public in one or more European jurisdictions. Investors should continue to consider the terms of investment in any Fund (or Share Class thereof) carefully and seek professional investment advice before taking any decision to invest in such Fund (or Share Class thereof).